The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.
<h4>Background</h4>Given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (CF), it is essential to enhance our knowledge on the composition of the microbial community to improve patient management. In this study, we developed a pyrosequencing approach to...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d131a0ce58e943cc87600f382182944e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:d131a0ce58e943cc87600f382182944e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:d131a0ce58e943cc87600f382182944e2021-11-18T07:20:17ZThe airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.1932-620310.1371/journal.pone.0036313https://doaj.org/article/d131a0ce58e943cc87600f382182944e2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22558432/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (CF), it is essential to enhance our knowledge on the composition of the microbial community to improve patient management. In this study, we developed a pyrosequencing approach to extensively explore the diversity and dynamics of fungal and prokaryotic populations in CF lower airways.<h4>Methodology and principal findings</h4>Fungi and bacteria diversity in eight sputum samples collected from four adult CF patients was investigated using conventional microbiological culturing and high-throughput pyrosequencing approach targeting the ITS2 locus and the 16S rDNA gene. The unveiled microbial community structure was compared to the clinical profile of the CF patients. Pyrosequencing confirmed recently reported bacterial diversity and observed complex fungal communities, in which more than 60% of the species or genera were not detected by cultures. Strikingly, the diversity and species richness of fungal and bacterial communities was significantly lower in patients with decreased lung function and poor clinical status. Values of Chao1 richness estimator were statistically correlated with values of the Shwachman-Kulczycki score, body mass index, forced vital capacity, and forced expiratory volume in 1 s (p = 0.046, 0.047, 0.004, and 0.001, respectively for fungal Chao1 indices, and p = 0.010, 0.047, 0.002, and 0.0003, respectively for bacterial Chao1 values). Phylogenetic analysis showed high molecular diversities at the sub-species level for the main fungal and bacterial taxa identified in the present study. Anaerobes were isolated with Pseudomonas aeruginosa, which was more likely to be observed in association with Candida albicans than with Aspergillus fumigatus.<h4>Conclusions</h4>In light of the recent concept of CF lung microbiota, we viewed the microbial community as a unique pathogenic entity. We thus interpreted our results to highlight the potential interactions between microorganisms and the role of fungi in the context of improving survival in CF.Laurence DelhaesSébastien MonchyEmilie FréalleChristine HubansJulia SalleronSylvie LeroyAnne PrevotatFrédérick WalletBenoit WallaertEduardo Dei-CasTelesphore Sime-NgandoMagali ChabéEric ViscogliosiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 4, p e36313 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Laurence Delhaes Sébastien Monchy Emilie Fréalle Christine Hubans Julia Salleron Sylvie Leroy Anne Prevotat Frédérick Wallet Benoit Wallaert Eduardo Dei-Cas Telesphore Sime-Ngando Magali Chabé Eric Viscogliosi The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. |
| description |
<h4>Background</h4>Given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (CF), it is essential to enhance our knowledge on the composition of the microbial community to improve patient management. In this study, we developed a pyrosequencing approach to extensively explore the diversity and dynamics of fungal and prokaryotic populations in CF lower airways.<h4>Methodology and principal findings</h4>Fungi and bacteria diversity in eight sputum samples collected from four adult CF patients was investigated using conventional microbiological culturing and high-throughput pyrosequencing approach targeting the ITS2 locus and the 16S rDNA gene. The unveiled microbial community structure was compared to the clinical profile of the CF patients. Pyrosequencing confirmed recently reported bacterial diversity and observed complex fungal communities, in which more than 60% of the species or genera were not detected by cultures. Strikingly, the diversity and species richness of fungal and bacterial communities was significantly lower in patients with decreased lung function and poor clinical status. Values of Chao1 richness estimator were statistically correlated with values of the Shwachman-Kulczycki score, body mass index, forced vital capacity, and forced expiratory volume in 1 s (p = 0.046, 0.047, 0.004, and 0.001, respectively for fungal Chao1 indices, and p = 0.010, 0.047, 0.002, and 0.0003, respectively for bacterial Chao1 values). Phylogenetic analysis showed high molecular diversities at the sub-species level for the main fungal and bacterial taxa identified in the present study. Anaerobes were isolated with Pseudomonas aeruginosa, which was more likely to be observed in association with Candida albicans than with Aspergillus fumigatus.<h4>Conclusions</h4>In light of the recent concept of CF lung microbiota, we viewed the microbial community as a unique pathogenic entity. We thus interpreted our results to highlight the potential interactions between microorganisms and the role of fungi in the context of improving survival in CF. |
| format |
article |
| author |
Laurence Delhaes Sébastien Monchy Emilie Fréalle Christine Hubans Julia Salleron Sylvie Leroy Anne Prevotat Frédérick Wallet Benoit Wallaert Eduardo Dei-Cas Telesphore Sime-Ngando Magali Chabé Eric Viscogliosi |
| author_facet |
Laurence Delhaes Sébastien Monchy Emilie Fréalle Christine Hubans Julia Salleron Sylvie Leroy Anne Prevotat Frédérick Wallet Benoit Wallaert Eduardo Dei-Cas Telesphore Sime-Ngando Magali Chabé Eric Viscogliosi |
| author_sort |
Laurence Delhaes |
| title |
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. |
| title_short |
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. |
| title_full |
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. |
| title_fullStr |
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. |
| title_full_unstemmed |
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. |
| title_sort |
airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/d131a0ce58e943cc87600f382182944e |
| work_keys_str_mv |
AT laurencedelhaes theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT sebastienmonchy theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT emiliefrealle theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT christinehubans theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT juliasalleron theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT sylvieleroy theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT anneprevotat theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT frederickwallet theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT benoitwallaert theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT eduardodeicas theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT telesphoresimengando theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT magalichabe theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT ericviscogliosi theairwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT laurencedelhaes airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT sebastienmonchy airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT emiliefrealle airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT christinehubans airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT juliasalleron airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT sylvieleroy airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT anneprevotat airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT frederickwallet airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT benoitwallaert airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT eduardodeicas airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT telesphoresimengando airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT magalichabe airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement AT ericviscogliosi airwaymicrobiotaincysticfibrosisacomplexfungalandbacterialcommunityimplicationsfortherapeuticmanagement |
| _version_ |
1718423628498862080 |